Award recordCONTRACT

GILEAD SCIENCES INC

PIID VA26017J1641· VHA· 260-NETWORK CONTRACT OFFICE 20 (36C260)· 6505 · DRUGS AND BIOLOGICALS· FY2017· $71,400 net obligations· UEI FPJMGUK1BYH8· CA

Description

BULK FUNDING FOR FY-17 - DRUG: AMBRISENTAN 5MG TABS (LETAIRIS)

First action · last action
2016-10-01 · 2017-12-06
Transactions
3
First transaction's obligation
$44,625
Base + all options value (sum of deltas)
$71,400
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
1
SDVOSB flag on record
No
Parent IDV
VA797P16A0013
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING

Modification chain · 3 transactions

Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.

$71,400$0Base award · 2016-10-01 · this action $44,625 · running total $44,625Modification P00001 · 2017-05-23 · this action $26,775 · running total $71,400Modification P00002 · 2017-12-06 · this action -$0 · running total $71,400
  • Base2016-10-01+$44,625= $44,625
  • Mod P000012017-05-23+$26,775= $71,400
  • Mod P000022017-12-06-$0= $71,400
TransactionAction dateThis action (delta)Running totalDescription on this transaction
Base2016-10-01+$44,625$44,625BULK FUNDING FOR FY-17 - DRUG: AMBRISENTAN 5MG TABS (LETAIRIS)
Mod P00001· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE2017-05-23+$26,775$71,400BULK FUNDING FOR FY-17 - DRUG: AMBRISENTAN 5MG TABS (LETAIRIS)
Mod P00002· OTHER ADMINISTRATIVE ACTION2017-12-06−$0$71,400BULK FUNDING FOR FY-17 - DRUG: AMBRISENTAN 5MG TABS (LETAIRIS)

Related awards · 11

Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.

Other VA awards to the same recipient (UEI FPJMGUK1BYH8)

AwardOffice · PSC / listingNet obligationsFY
36C26125N0499261-NETWORK CONTRACT OFFICE 21 (36C261) · 6505 · DRUGS AND BIOLOGICALS$14,894FY2025
36C26025F0137260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$3,103FY2025
36C26025F0134260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$2,482FY2025
36C24524N0911245-NETWORK CONTRACT OFFICE 5 (36C245) · 6505 · DRUGS AND BIOLOGICALS$14,938FY2024
36C26024F0466260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$47,797FY2024
36C26024F0440260-NETWORK CONTRACT OFFICE 20 (36C260) · 6505 · DRUGS AND BIOLOGICALS$47,797FY2024

Other recipients under 6505 from 260-NETWORK CONTRACT OFFICE 20 (36C260) (most recent first)

AwardRecipientOfficeNet obligationsFY
36C26026F0379COSETTE PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$3,466FY2026
36C26026P0671MCKESSON PLASMA AND BIOLOGICS LLC260-NETWORK CONTRACT OFFICE 20 (36C260)$18,262FY2026
36C26026F0349AGIOS PHARMACEUTICALS, INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$73,080FY2026
36C26026F0306BRACCO DIAGNOSTICS INC.260-NETWORK CONTRACT OFFICE 20 (36C260)$337,422FY2026
36C26026F0298PROGENICS PHARMACEUTICALS INC260-NETWORK CONTRACT OFFICE 20 (36C260)$469,134FY2026

Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA26017J1641_3600_VA797P16A0013_3600 · retrieved 2026-09-27.